+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Aphasia Drug"

From
Primary Progressive Aphasia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Primary Progressive Aphasia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Aphasia is a language disorder that affects the ability to communicate. Aphasia drugs are used to treat this condition and are part of the Central Nervous System (CNS) drug market. These drugs are typically prescribed to improve language skills, such as speaking, understanding, reading, and writing. They can also help with memory and problem-solving. Commonly used aphasia drugs include anticonvulsants, antidepressants, and antipsychotics. The CNS drug market is highly competitive, with many companies developing and marketing drugs for a variety of neurological conditions. Some of the major players in the aphasia drug market include Pfizer, Novartis, GlaxoSmithKline, and Merck. Other companies, such as Lundbeck, Sunovion, and Otsuka, are also active in the market. Show Less Read more